PrEP therapies utter new hope in HIV preventive landscape as vaccine failures amass
Research activity in the human immunodeficiency viruses space (HIV) is pivoting towards pre-exposure prophylaxis (PrEP) therapies as vaccine failures rack …
Post
-
-
EMA launches ESMP for better management of drug shortages in EU
The first version of the European Shortages Monitoring Platform (ESMP) has gone live to help marketing authorisation holders (MAHs) report …
-
University of Birmingham identifies target to reduce GVHD risk
The University of Birmingham researchers have identified CD70 as a key target to reduce the risk of graft-versus-host disease (GVHD) …
-
UK Government to launch first ever men’s health strategy
As Men’s Health Awareness Month comes to an end, UK Health Secretary Wes Streeting has announced the development of a …
-
UK reports near eradication of meningitis C amid declining vaccine uptake
New data from the UK Health Security Agency (UKHSA) indicates significant progress in combating meningitis caused by meningococcal group C …
-
Allink Biotherapeutics secures funding to advance ADC pipeline
Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its bispecific antibody and …
-
Formosa and Medvisis agree on post-operative eye pain therapy
Formosa Pharmaceuticals in Taiwan has signed an exclusive licensing agreement with Medvisis Switzerland to commercialise clobetasol propionate ophthalmic suspension, 0.05% …
-
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Having promised to “Make America Healthy Again”, the administration in Trump’s second presidency looks set to shake up the health …
-
Advanz Pharma’s liver disease drug pulled from European market after court hearing
Advanz Pharma’s liver disease drug Ocaliva (obeticholic acid) will no longer be available in Europe after the General Court of …
-
Kronos Bio announces interim CEO and workforce cuts of 83%
Kronos Bio has announced the appointment of Deborah Knobelman as president and interim chief executive officer, effective from 3 December …
-
Trump agency nominations show pharma industry as divided as US
As US President-Elect Donald Trump, who will return to the White House in late January 2025, appoints healthcare agency heads, …
-
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, marking it as the first treatment in the country authorised to …
-
Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition
Climate change’s escalating impact is reshaping the infectious disease landscape in pervasive and profound ways. Rising temperatures are expanding the …
-
CervoMed’s stock rises as FDA grants orphan drug status to dementia drug
The US Food and Drug Administration (FDA) has granted orphan drug designation to CervoMed’s lead investigational therapy neflamapimod for the …
-
Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat
The US Food and Drug Administration (FDA) has declined to approve Applied Therapeutics’ govorestat for classic galactosemia, prolonging the wait …
